Dare Bioscience

DARE NASDAQ
0.8001
-0.0092
-1.14%
Opening 14:17 06/25 EDT
Open
0.7603
Prev Close
0.8093
High
0.8195
Low
0.7603
Volume
71.02K
Avg Vol (3M)
493.65K
52 Week High
3.250
52 Week Low
0.6000
% Turnover
0.43%
Market Cap
13.35M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Dare Bioscience DARE stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Dare Bioscience, Inc., formerly Cerulean Pharma Inc., is a healthcare company. The Company is focused on the development and commercialization of products in women’s reproductive health. Its lead product candidate is Ovaprene, a clinical stage, non-hormonal contraceptive ring. The Company is developing Ovaprene to provide protection over multiple weeks of use and require no intervention at the time of intercourse. Ovaprene has a custom intravaginal ring design, with a permeable mesh in the center of the ring that creates a partial barrier to sperm, and a mechanism to release locally acting spermiostatic agents through the ring. The combination of these two complementary approaches produces attractive contraceptive efficacy outcomes that are consistent with the effective barrier option, the diaphragm, and short-acting hormonal options, such as oral pill, patches and vaginal ring.
MORE >

Recently

Name
Price
%Change